A Study of the Efficacy and Safety of Different Dosages of Rivaroxaban in Patients with Atrial Fibrillation

YAN Xinsheng, ZHANG Litao, LIU Xiaohui, ZHANG Zhenlu, YAN Bao, XIA Lingyun, WANG Xiaosu

PDF(1021 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1021 KB)
Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (2) : 270-275. DOI: 10.11748/bjmy.issn.1006-1703.2024.02.015
Clinical Investigation

A Study of the Efficacy and Safety of Different Dosages of Rivaroxaban in Patients with Atrial Fibrillation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(2): 270-275 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.02.015

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1021 KB)

Accesses

Citation

Detail

Sections
Recommended

/